EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation

Paula Cilleros-Holgado iD, David Gómez-Fernández, Rocío Piñero-Pérez, José Manuel Romero Domínguez, Marta Talaverón-Rey, Diana Reche-López, Juan Miguel Suárez-Rivero, Mónica Álvarez-Córdoba, Ana Romero-González, Alejandra López-Cabrera, Marta Castro De Oliveira, Andrés Rodríguez-Sacristan und 1 weitere

Biomolecules · 2024

DOI: 10.3390/biom14050598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Paula Cilleros-Holgado und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), 41013 Sevilla, Spain. Hauptthemen laut MEDLINE: Fibroblasts, Glucosides, Mitochondria, Mitochondrial Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Junta de Andalucía, Ministerio de Sanidad, Spain; and the Fondo Europeo de Desarrollo Regional (FEDER Unión Europea), Spanish Ministry of Education, Culture, and Sport.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary mitochondrial diseases result from mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA) genes, encoding proteins crucial for mitochondrial structure or function. Given that few disease-specific therapies are available for mitochondrial diseases, novel treatments to reverse mitochondrial dysfunction are necessary. In this work, we explored new therapeutic options in mitochondrial diseases using fibroblasts and induced neurons derived from patients with mutations in the GFM1 gene. This gene encodes the essential mitochondrial translation elongation factor G1 involved in mitochondrial protein synthesis. Due to the severe mitochondrial defect, mutant GFM1 fibroblasts cannot survive in galactose medium, making them an ideal screening model to test the effectiveness of pharmacological compounds. We found that the combination of polydatin and nicotinamide enabled the survival of mutant GFM1 fibroblasts in stress medium. We also demonstrated that polydatin and nicotinamide upregulated the mitochondrial Unfolded Protein Response (mtUPR), especially the SIRT3 pathway. Activation of mtUPR partially restored mitochondrial protein synthesis and expression, as well as improved cellular bioenergetics. Furthermore, we confirmed the positive effect of the treatment in GFM1 mutant induced neurons obtained by direct reprogramming from patient fibroblasts. Overall, we provide compelling evidence that mtUPR activation is a promising therapeutic strategy for GFM1 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsGlucosidesMitochondriaMitochondrial DiseasesNiacinamideStilbenesUnfolded Protein ResponseHumansMitochondrial ProteinsMutationNeuronsPhenotypePeptide Elongation Factor G

Stichwörter der Autor:innen

EF-G1GFM1direct reprogrammingfibroblastsinduced neuronsmitochondriamitochondrial diseasesmtUPRtreatment

Substanzen

GlucosidesMitochondrial ProteinsNiacinamidepolydatinStilbenesGFM1 protein, humanPeptide Elongation Factor G

Autor:innen und Institutionen

  • Centro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), 41013 Sevilla, Spain.
  • Neuropediatria, Neurolinkia, C. Jardín de la Isla, 8, Local 4 y 5, 41014 Sevilla, Spain.
  • FEA Pediatría, Centro Universitario Hospitalar de Faro, R. Leão Penedo, 8000-386 Faro, Portugal.
  • Neuropediatría, Servicio de Pediatría, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
  • Departamento de Farmacología, Radiología y Pediatría, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain.

ORCID-Profile: Paula Cilleros-Holgado, José Antonio Sánchez-Alcázar

Förderung

  • Instituto de Salud Carlos III
  • Junta de Andalucía
  • Ministerio de Sanidad, Spain; and the Fondo Europeo de Desarrollo Regional (FEDER Unión Europea), Spanish Ministry of Education, Culture, and Sport
  • European Regional Development Fund (ERDF) and by the Regional Ministry of Economic Transformation, Industry, Knowledge, and Universities of the Junta de Andalu…

Zitieren

APA

Cilleros-Holgado, P., Gómez-Fernández, D., Piñero-Pérez, R., Romero Domínguez, J. M., Talaverón-Rey, M., Reche-López, D., Suárez-Rivero, J. M., Álvarez-Córdoba, M., Romero-González, A., López-Cabrera, A., Oliveira, M. C., Rodríguez-Sacristan, A., & Sánchez-Alcázar, J. A. (2024). Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation. Biomolecules. https://doi.org/10.3390/biom14050598

Vancouver

Cilleros-Holgado P, Gómez-Fernández D, Piñero-Pérez R, Romero Domínguez JM, Talaverón-Rey M, Reche-López D, et al. Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation. Biomolecules. 2024. doi:10.3390/biom14050598

BibTeX
@article{CillerosHolgado2024,
  author = {Cilleros-Holgado, Paula and Gómez-Fernández, David and Piñero-Pérez, Rocío and Romero Domínguez, José Manuel and Talaverón-Rey, Marta and Reche-López, Diana and Suárez-Rivero, Juan Miguel and Álvarez-Córdoba, Mónica and Romero-González, Ana and López-Cabrera, Alejandra and Oliveira, Marta Castro De and Rodríguez-Sacristan, Andrés and Sánchez-Alcázar, José Antonio},
  title = {Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14050598}
}
Kostenlos starten →